Pulmonx CorpLUNGEarnings & Financial Report
Nasdaq
NextFeb 27, 2026
LUNG Q3 2025 Key Financial Metrics
Revenue
$21.5M
Gross Profit
$16.1M
Operating Profit
$-14.4M
Net Profit
$-14.0M
Gross Margin
74.7%
Operating Margin
-66.9%
Net Margin
-64.9%
YoY Growth
5.5%
EPS
$-0.34
Financial Flow
Pulmonx Corp Q3 2025 Financial Summary
Pulmonx Corp reported revenue of $21.5M for Q3 2025, with a net profit of $-14.0M (-64.9% margin). Cost of goods sold was $5.5M, operating expenses totaled $30.4M.
Key Financial Metrics
| Total Revenue | $21.5M |
|---|---|
| Net Profit | $-14.0M |
| Gross Margin | 74.7% |
| Operating Margin | -66.9% |
| Report Period | Q3 2025 |
Pulmonx Corp Annual Revenue by Year
Pulmonx Corp annual revenue history includes year-by-year totals (for example, 2024 revenue was $83.8M).
| Year | Annual Revenue |
|---|---|
| 2024 | $83.8M |
| 2023 | $68.7M |
| 2022 | $53.7M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.3M | $18.9M | $20.8M | $20.4M | $23.8M | $22.5M | $23.9M | $21.5M |
| YoY Growth | 25.0% | 29.7% | 20.9% | 15.4% | 23.3% | 19.5% | 14.8% | 5.5% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $177.8M | $164.6M | $172.6M | $167.4M | $162.8M | $150.7M | $147.2M | $138.3M |
| Liabilities | $59.5M | $54.1M | $71.4M | $73.5M | $77.0M | $73.1M | $78.1M | $78.2M |
| Equity | $118.3M | $110.5M | $101.2M | $93.9M | $85.8M | $77.7M | $69.1M | $60.0M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-8.4M | $-11.8M | $-5.8M | $-7.2M | $-6.7M | $-13.2M | $-3.9M | $-8.2M |